AnaptysBio, Inc. ANAB Payments Of Advance Future Royalties Issuance Costs
Payments Of Advance Future Royalties Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept anab:PaymentsOfAdvanceFutureRoyaltiesIssuanceCosts.
The official record: AnaptysBio, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s payments of advance future royalties issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s payments of advance future royalties issuance costs?
- AnaptysBio, Inc. (ANAB) reported payments of advance future royalties issuance costs of $0 in Q4 2025.
- How has AnaptysBio, Inc.'s payments of advance future royalties issuance costs changed year-over-year?
- AnaptysBio, Inc.'s payments of advance future royalties issuance costs decreased by 100.0% year-over-year, from $25.75K to $0.
- What is the long-term trend for AnaptysBio, Inc.'s payments of advance future royalties issuance costs?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s payments of advance future royalties issuance costs has grown at a -100.0% compound annual growth rate (CAGR), from $255K to $0.
- What does payments of advance future royalties issuance costs mean?
- This represents the transaction costs incurred to secure financing through the sale of future royalty rights. These costs include advisory, legal, and administrative fees necessary to finalize the agreement. Tracking these expenses provides insight into the friction costs associated with alternative financing strategies.